SFS
SYRS

Sowell Financial Services’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Sowell Financial Services’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed – – 2852
2021
Q1 		$0 Buy
+6
New +$623 ﹤0.01% 3334
2020
Q4 		– Sell
-21
Closed -$2K – 2883
2020
Q3 		$2K Buy
+21
New +$2.39K ﹤0.01% 2289

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Sowell Financial Services's SYRS Position: Q2 2021 in Review

Sowell Financial Services sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2021, closing a stake of 6 shares.

Sowell Financial Services first reported a position in SYRS in Q3 2020 and held it in 2 quarters. The position peaked at $2K in Q3 2020. 100 funds tracked by Wall St. Rank hold SYRS as of Q2 2021.

  • Sowell Financial Services reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 6 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2021.
  • Sowell Financial Services first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Sowell Financial Services's Syros Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q3 2020.
  • 100 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.